List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 24 studies with search of:   "9-nitrocamptothecin"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Aerosol L9-NC and Temozolomide in Ewing's Sarcoma
Condition: Ewing's Sarcoma
Interventions: Drug: Temozolomide;   Drug: L9-NC
2 Completed Study of Aerosolized Liposomal 9-Nitro-20 (S)- Camptothecin (L9NC)
Conditions: Lung Diseases;   Cancer
Intervention: Drug: Liposomal 9-Nitrocamptothecin
3 Recruiting Study of Rubitecan in Cancer Patients With Renal or Hepatic Dysfunction
Condition: Tumors
Intervention: Drug: Rubitecan
4 Recruiting Orathecin + Gemcitabine Versus Placebo + Gemcitabine in Chemonaive Non-Resectable Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention: Drug: Rubitecan
5 Completed Phase II Study of Aerosolized Liposomal 9-Nitro-20 (S)- Camptothecin (L9NC)
Conditions: Corpus Uteri;   Endometrial Cancer
Intervention: Drug: 9-NC in aerosol reservoir
6 Completed Aerosolized Liposomal Camptothecin in Patients With Metastatic or Recurrent Cancer of the Endometrium or the Lung
Conditions: Corpus Uteri;   Lung Cancer
Intervention: Drug: 9-NC in aerosol reservoir
7 Active, not recruiting Nitrocamptothecin in Treating Patients With Locally Advanced or Metastatic Stomach Cancer That Cannot Be Removed During Surgery
Conditions: Esophageal Cancer;   Gastric Cancer
Intervention: Drug: rubitecan
8 Completed Pharmacology Study of Aerosolized Liposomal
Conditions: Lung Diseases;   Cancer
Intervention: Drug: L9NC: Liposomal 9-Nitro-20 (S)-Camptothecin
9 Completed Nitrocamptothecin in Treating Patients With Metastatic Melanoma
Condition: Melanoma (Skin)
Intervention: Drug: rubitecan
10 Completed Nitrocamptothecin in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Condition: Breast Cancer
Intervention: Drug: rubitecan
11 Completed Nitrocamptothecin in Treating Patients With Soft Tissue Sarcomas
Conditions: Gastrointestinal Stromal Tumor;   Sarcoma;   Small Intestine Cancer
Intervention: Drug: rubitecan
12 Active, not recruiting Nitrocamptothecin Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: gemcitabine hydrochloride;   Drug: rubitecan
13 Active, not recruiting Nitrocamptothecin Compared With Other Chemotherapy in Treating Patients With Recurrent or Refractory Cancer of the Pancreas
Condition: Pancreatic Cancer
Interventions: Drug: fluorouracil;   Drug: gemcitabine hydrochloride;   Drug: mitomycin C;   Drug: rubitecan
14 Active, not recruiting Nitrocamptothecin in Treating Patients With Advanced or Recurrent Colorectal Cancer
Condition: Colorectal Cancer
Intervention: Drug: rubitecan
15 Active, not recruiting Nitrocamptothecin in Treating Patients With Glioblastoma Multiforme
Condition: Brain and Central Nervous System Tumors
Intervention: Drug: rubitecan
16 Active, not recruiting Nitrocamptothecin in Treating Patients With Advanced Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Drug: rubitecan
17 Active, not recruiting Nitrocamptothecin or Fluorouracil in Treating Patients With Recurrent or Refractory Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: fluorouracil;   Drug: rubitecan
18 Active, not recruiting Nitrocamptothecin in Treating Patients With Advanced Small Cell Lung Cancer
Condition: Lung Cancer
Intervention: Drug: rubitecan
19 Active, not recruiting Nitrocamptothecin in Treating Patients With Metastatic Cancer of the Urinary Tract
Conditions: Bladder Cancer;   Transitional Cell Cancer of the Renal Pelvis and Ureter;   Urethral Cancer
Intervention: Drug: rubitecan
20 Completed Pharmacology Study of Aerosolized Liposomal 9-Nitro-20 (S)-Camptothecin (L9NC)
Conditions: Corpus Uteri;   Endometrial Cancer
Intervention:

Previous Page Studies Shown (1-20) Next (21-24)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options